Sign in
Taking people in United StatesNo phase

Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression

Key facts

Who runs it
University of Michigan
Where
Ann Arbor, United StatesSee the site
Trial code
Status
Recruiting
People taking part
30 people, planned
Started
29 Jul 2026
Expected to end
May 2027
Type of study
Interventional
Treatments tested
  • Light therapy
Record updated
14 August 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • ≤ 6 months postpartum
  • EPDS score >10

Who cannot take part

  • Current use of photosensitizing medications
  • Psychotherapy or psychotropic medications started/dose changed in past month (psychotherapy started and/or current medication at stable dose ≥ 4 weeks are permitted)
  • Current or past-year substance use disorder
  • Lifetime history of bipolar disorder or psychotic disorder
  • Retinal pathology or history of eye surgery
  • Untreated sleep-disordered breathing, untreated restless legs syndrome, or narcolepsy
  • Medical conditions contraindicated for mBLT (e.g., epilepsy/seizures)
  • Active suicidal intent

Where in United States

  • University of MichiganAnn Arbor, United StatesContact: Kelley DuBucTaking people

About the trial

What the trial wants to find out

The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.

The group in the trial

  • Light therapyTreatment being tested

    Participants in the arm will be approximately 30 women who are within 6 months postpartum and have an Edinburgh Postnatal Depression Scale (EPDS) score \> 10.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
14 August 2026